Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine prophylaxis for platinum chemotherapy-induced neuropathy
IRCT20250909067196N1Phase 3Completed
- Sponsor
- Aja University of Medical Sciences
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of duloxetine in chemotherapy-induced peripheral neuropathy (CIPN) (2 arms), sponsored by Aja University of Medical Sciences. Primary endpoint: Incidence of neuropathy. Started Feb 2026; status: completed.
02
Drugs
duloxetine
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on IRCT20250909067196N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250909067196N1.